EW - Edwards Lifesciences Non-GAAP EPS of $0.61 misses by $0.01 revenue of $1.32B misses by $10M
- Edwards Lifesciences press release ( NYSE: EW ): Q3 Non-GAAP EPS of $0.61 misses by $0.01 .
- Revenue of $1.32B (+0.8% Y/Y) misses by $10M .
- Q3 TAVR sales grew 1%; constant currency sales grew 6%
- Outlook: 2022 adjusted EPS guidance revised to the range of $2.40 to $2.50, compared to 2021 adjusted EPS of $2.22, vs. consensus of $2.52.
For further details see:
Edwards Lifesciences Non-GAAP EPS of $0.61 misses by $0.01, revenue of $1.32B misses by $10M